Efraín Chavarría-Avila (Efrain Chavarria-Avila)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Disease Activity

Multiple Sclerosis

Top Venues

Journal of clinical medicine

Immunopharmacology and immunotoxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Oscar-Enrique Pizano-Martínez, Edgar Mendieta-Condado, Mónica Vázquez-Del Mercado, Erika Aurora Martínez-García, Efraín Chavarría-Avila, Daniel Ortuño-Sahagún, Ana Laura Márquez-Aguirre
Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases. Journal of clinical medicine 12 (9) (2023)
Oscar-Enrique Pizano-Martínez, Edgar Mendieta-Condado, Mónica Vázquez-Del Mercado, Erika Aurora Martínez-García, Efraín Chavarría-Avila, Daniel Ortuño-Sahagún, Ana Laura Márquez-Aguirre
Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases. Journal of clinical medicine 12 (9) (2023)
Martha Rocio Hernández-Preciado, Jazmin Marquez-Pedroza, Nayeli Alejandra Sánchez-Rosales, José de Jesús García-Rivera, Antonio Kobayashi-Gutiérrez, Blanca Miriam Torres-Mendoza, Efraín Chavarría-Avila, Raúl Alejandro Montaño-Serrano, Fernando Cortes-Enriquez, Mario Alberto Mireles-Ramírez
Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Cohort Study. Journal of clinical medicine 11 (13) (2022)
Mónica Vázquez-Del Mercado, Erika Aurora Martínez-García, Adrián Daneri-Navarro, Eduardo Gomez-Bañuelos, Beatriz-Teresita Martín-Márquez, Oscar-Enrique Pizano-Martínez, Eduardo A Wilson-Manríquez, Esther Guadalupe Corona-Sánchez, Efraín Chavarría-Avila, Flavio Sandoval-García, Minoru Satoh
Presence of anti-TIF-1γ, anti-Ro52, anti-SSA/Ro60 and anti-Su/Ago2 antibodies in breast cancer: a cross-sectional study. Immunopharmacology and immunotoxicology 43 (3) (2021)